The effect of titanium with heparin/BMP-2 complex for improving osteoblast activity

Carbohydrate Polymers

Volumn 98, Issue 1, 2013, Pages 546-554

  Lee, Su Young ^a   Yun, Young Pil ^b   Song, Hae Ryong ^b   Chun, Heung Jae ^c   Yang, Dae Hyeok ^c   Park, Kyeongsoon ^d   Kim, Sung Eun ^b  

^a The Catholic University of Korea   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

^d Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

Bone morphogenic protein 2 (BMP 2); Heparin; Osteoblast activity; Titanium

Indexed keywords

AMINO ACIDS; BONE; CONTACT ANGLE; GRAFTING (CHEMICAL); PHASE LOCKED LOOPS; POLYSACCHARIDES; SCANNING ELECTRON MICROSCOPY; SUBSTRATES; TITANIUM; TITANIUM METALLOGRAPHY; X RAY PHOTOELECTRON SPECTROSCOPY;

BONE MORPHOGENIC PROTEIN; CALCIUM DEPOSITION; CHEMICAL GRAFTING; CONDENSING AGENTS; HEPARIN; OSTEOCALCIN; POLY-L-LYSINE; TI SUBSTRATES;

TITANIUM COMPOUNDS;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; HEPARIN; IMMOBILIZED PROTEIN; NANOPARTICLE; OSTEOCALCIN; POLYLYSINE; TITANIUM;

ARTICLE; BONE MORPHOGENIC PROTEIN-2 (BMP-2); CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; OSTEOBLAST; OSTEOBLAST ACTIVITY; SURFACE PROPERTY; TUMOR CELL LINE;

BONE MORPHOGENIC PROTEIN-2 (BMP-2); HEPARIN; OSTEOBLAST ACTIVITY; TITANIUM;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION; HEPARIN; HUMANS; IMMOBILIZED PROTEINS; NANOPARTICLES; OSTEOBLASTS; OSTEOCALCIN; POLYLYSINE; SURFACE PROPERTIES; TITANIUM;

EID: 84885111763     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2013.05.095     Document Type: Article

References (43)

1. Balasundaram, G., & Webster, T. J. (2007). Increased osteoblast adhesion on nanograined Ti modified with KRSR. Journal of Biomedical Materials Research Part A, 80, 602-611. (Pubitemid 46239072)
2. Bancroft, G. N., Sikavitsas, V. I., van den Dolder, J., Sheffield, T. L., Ambrose, C. G., Jansen, J. A., et al. (2002). Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proceedings of the National Academy of Sciences of the United States of America, 99, 12600-12605.
3. Boyne, P. J. (2001). Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects. Journal of Bone and Joint Surgery, 83, S146-S150.
4. Buser, D., Belser, U. C., & Lang, N. P. (1998). The original one-stage dental implant system and its clinical application. Periodontology 2000, 17, 106-118. (Pubitemid 128556022)
5. Chung, H. J., Kim, H. K., Yoon, J. J., & Park, T. G. (2006). Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery. Pharmaceutical Research, 23, 1835-1841. (Pubitemid 44200547)
6. Das, K., Bose, S., & Bandyopadhyay, A. (2007). Surface modifications and cellmaterials interactions with anodized Ti. Acta Biomaterialia, 3, 573-585. (Pubitemid 46865778)
7. Groeneveld, E. H., & Burger, E. H. (2000). Bone morphogenetic proteins in human bone regeneration. European Journal of Endocrinology/European Federation of Endocrine Societies, 142, 9-21. (Pubitemid 30094193)
8. Herford, A. S., & Boyne, P. J. (2008). Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). Journal of Oral and Maxillofacial Surgery, 66, 616-624. (Pubitemid 351381799)
9. Ishibe, T., Goto, T., Kodama, T., Miyazaki, T., Kobayashi, S., & Takahashi, T. (2009). Bone formation on apatite-coated titanium with incorporated BMP-2/heparin in vivo. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics, 108, 867-875.
10. Jeon, O., Song, S. J., Kang, S. W., Putnam, A. J., & Kim, B. S. (2007). Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(l-lactic-co-glycolic acid) scaffold. Biomaterials, 28, 2763-2771. (Pubitemid 46413347)
11. Karageorgiou, V., Meinel, L., Hofmann, S., Malhotra, A., Volloch, V., & Kaplan, D. (2004). Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. Journal of Biomedical Materials Research Part A, 71, 528-537. (Pubitemid 39489907)
12. Katz, J. M., Nataraj, C., Jaw, R., Deigl, E., & Bursac, P. (2009). Demineralized bone matrix as an osteoinductive biomaterial and in vitro predictors of its biological potential. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 89, 127-134.
13. Kim, S. E., Jeon, O., Lee, J. B., Bae, M. S., Chun, H. J., Moon, S. H., et al. (2008). Enhancement of ectopic bone formation by bone morphogenetic protein-2 delivery using heparin-conjugated PLGA nanoparticles with transplantation of bone marrow-derived mesenchymal stem cells. Journal of Biomedical Science, 15, 771-777.
14. Kim, S. E., Song, S. H., Yun, Y. P., Choi, B. J., Kwon, I. K., Bae, M. S., et al. (2011). The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function. Biomaterials, 32, 366-373.
15. Kunishima, M., Kawachi, C., Morita, J., Terao, K., Iwasaki, F., & Tani, S. (1999). 4-(4,6- Dimethoxy-1,3,5-triazin-2-yl)-4-methyl-morpholinium chloride: An efficient condensing agent leading to the formation of amides and esters. Tetrahedron, 55, 13159-13170. (Pubitemid 29502265)
16. Le Guillou-Buffello, D., Bareille, R., Gindre, M., Sewing, A., Laugier, P., & Amédée, J. (2008). Additive effect of RGD coating to functionalized titanium surfaces on human osteoprogenitor cell adhesion and spreading. Tissue Engineering Part A, 14, 1445-1455.
17. Lin, D., Li, Q., Li, W., & Swain, M. (2010). Bone remodeling induced by dental implants of functionally graded materials. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 92, 430-438.
18. Liu, Y., Enggist, L., Kuffer, A. F., Buser, D., & Hunziker, E. B. (2007). The influence of BMP-2 and its mode of delivery on the osteoconductivity of implant surfaces during the early phase of osseointegration. Biomaterials, 28, 2677-2686. (Pubitemid 46367217)
19. Lu, X., Wang, Y., Yang, X., Zhang, Q., Zhao, Z., Weng, L. T., et al. (2007). Spectroscopic analysis of titanium surface functional groups under various surface modification and their behaviors in vitro and in vivo. Journal of Biomedical Materials Research, 84A, 523-534.
20. Maegawa, N., Kawamura, K., Hirose, M., Yajima, H., Takakura, Y., & Ohgushi, H. (2007). Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). Journal of Tissue Engineering and Regenerative Medicine, 1, 306-313.
21. Michael, J., Schönzart, L., Israel, I., Beutner, R., Scharnweber, D., Worch, H., et al. (2009). Oligonucleotide-RGD peptide conjugates for surface modification of titanium implants and improvement of osteoblast adhesion. Bioconjugate Chemistry, 20, 710-718.
22. Miron, R. J., Oates, C. J., Molenberg, A., Dard, M., & Hamilton, D. W. (2010). The effect of enamel matrix proteins on the spreading, proliferation and differentiation of osteoblasts cultured on titanium surfaces. Biomaterials, 31, 449-460.
23. Nillesen, S. T., Geutjes, P. J., Wismans, R., Schalkwijk, J., Daamen, W. F., & van Kuppevelt, T. H. (2007). Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials, 28, 1123-1131. (Pubitemid 44809425)
24. Oya, K., Tanaka, Y., Saito, H., Kurashima, K., Nogi, K., Tsutsumi, H., et al. (2009). Calcification by MC3T3-E1 cells on RGD peptide immobilized on titanium through electrodeposited PEG. Biomaterials, 30, 1281-1286.
25. Perets, A., Baruch, Y., Weisbuch, F., Shoshany, G., Neufeld, G., & Cohen, S. (2003). Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. Journal of Biomedical Materials Research Part A, 65, 489-497. (Pubitemid 38075880)
26. Piskounova, S., Forsgren, J., Brohede, U., Engqvist, H., & Strømme, M. (2009). In vitro characterization of bioactive titanium dioxide/hydroxyapatite surfaces functionalized with BMP-2. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 91, 780-787.
27. Puleo, D. A., & Nanci, A. (1999). Understanding and controlling the bone-implant interface. Biomaterials, 20, 2311-2321.
28. Sasisekharan, R., Ernst, S., & Venkataraman, G. (1997). On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans. Angiogenesis, 1, 45-54. (Pubitemid 127505701)
29. Schuler, M., Hamilton, D. W., Kunzler, T. P., Sprecher, C. M., de Wild, M., Brunette, D. M., et al. (2009). Comparison of the response of cultured osteoblasts and osteoblasts outgrown from rat calvarial bone chips to nonfouling KRSR and FHRRIKA-peptide modified rough titanium surfaces. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 91, 517-527.
30. Shi, Z., Neoh, K. G., Kang, E. T., Poh, C. K., & Wang, W. (2009). Surface functionalization of titanium with carboxymethyl chitosan and immobilized bone morphogenetic protein-2 for enhanced osseointegration. Biomacromolecules, 10, 1603-1611.
31. Shi, Z., Neoh, K. G., Kang, E. T., Poh, C., & Wang, W. (2009). Titanium with surfacegrafted dextran and immobilized bone morphogenetic protein-2 for inhibition of bacterial adhesion and enhancement of osteoblast functions. Tissue Engineering Part A, 15, 417-426.
32. Song, S. J., Jeon, O., Yang, H. S., Han, D. K., & Kim, B. S. (2007). Effects of culture conditions on osteogenic differentiation in human mesenchymal stem cells. Journal of Microbiology and Biotechnology, 17, 1113-1119. (Pubitemid 47272263)
33. Steffens, G. C., Yao, C., Prével, P., Markowicz, M., Schenck, P., Noah, E. M., et al. (2004). Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor. Tissue Engineering, 10, 1502-1509. (Pubitemid 39557853)
34. Steinemann, S. G. (1998). Titanium-The material of choice? Periodontology 2000, 17, 7-21. (Pubitemid 128556013)
35. Takahashi, Y., Yamamoto, M., & Tabata, Y. (2005). Enhanced osteoinduction by controlled release of bone morphogenic protein-2 from biodegradable sponge composed of gelatin and tricalcium phosphate. Biomaterials, 26, 4856-4865. (Pubitemid 40343033)
36. Turksen, K., Bhargava, U., Moe, H. K., & Aubin, J. E. (1992). Isolation of monoclonal antibodies recognizing rat bone-associated molecules in vitro and in vivo. Journal of Histochemistry and Cytochemistry, 40, 1339-1352.
37. van den Beucken, J. J., Walboomers, X. F., Boerman, O. C., Vos, M. R., Sommerdijk, N. A., Hayakawa, T., et al. (2006). Functionalization of multilayered DNAcoatings with bone morphogenetic protein 2. Journal of Controlled Release, 113, 63-72. (Pubitemid 44177493)
38. Wissink, M. J., Beernink, R., Poot, A. A., Engbers, G. H., Beugeling, T., van Aken, W. G., et al. (2000). Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. Journal of Controlled Release, 64, 103-114. (Pubitemid 30035311)
39. Wissink, M. J., Beernink, R., Scharenborg, N. M., Poot, A. A., Engbers, G. H., Beugeling, T., et al. (2000). Endothelial cell seeding of (heparinized) collagen matrices: Effects of bFGF pre-loading on proliferation (after low density seeding) and pro-coagulant factors. Journal of Controlled Release, 67, 141-155. (Pubitemid 30303830)
40. Yang, H. S., La, W. G., Bhang, S. H., Jeon, J. Y., Lee, J. H., & Kim, B. S. (2010). Heparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-2. Tissue Engineering Part A, 16, 1225-1233.
41. Yang, H. S., La, W. G., Cho, Y. M., Shin, W., Yeo, G. D., & Kim, B. S. (2012). Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenic protein-2 carriers for bone regeneration. Experimental and Molecular Medicine, 44, 350-355.
42. Zhao, B., Katagiri, T., Toyoda, H., Takada, T., Fukuda, T., Chung, U. I., et al. (2006). Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenic-2. Journal of Biological Chemistry, 281, 23246-23253.
43. Zhu, L., Ye, X., Tang, G., Zhao, N., Gong, Y., Zhao, Y., et al. (2007). Biomimetic coating of compound titania and hydroxyapatite on titanium. Journal of Biomedical Materials Research Part A, 83, 1165-1175. (Pubitemid 350231779)